These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1818426)

  • 1. Effect of Paxirasol aerosol on the clinical condition and objective functional respiratory parameters of obstructive respiratory tract disease patients.
    Mészáros L; Molnár B; Beke M
    Ther Hung; 1991; 39(3):128-32. PubMed ID: 1818426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical observations with Paxirasol aerosol in patients suffering from chronic bronchitis accompanying silicosis.
    Alexy G; Lukács I; Sárdi F
    Ther Hung; 1992; 40(4):180-4. PubMed ID: 1345026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations with Paxirasol nasal spray therapy following open heart operations.
    Tomcsányi I
    Ther Hung; 1991; 39(4):183-4. PubMed ID: 1811330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromhexine and COPD.
    Gupta SK; Misra K
    J Assoc Physicians India; 1985 Mar; 33(3):250-1. PubMed ID: 4044491
    [No Abstract]   [Full Text] [Related]  

  • 6. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical observations with Paxirasol nasal spray.
    Szabadka H
    Ther Hung; 1992; 40(1):31-6. PubMed ID: 1585283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of Paxirasol in clinical practice.
    Nagy G
    Ther Hung; 1993; 41(3):100-6. PubMed ID: 8202865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for intercurrent respiratory infections in COLD patients: report on 200 patients.
    Turco P; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Dal Negro RW
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):260-2. PubMed ID: 6862731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucolytic acitivity of bromhexine guaiacol combination in chronic bronchopneumopathy patients].
    Clini V; Guadagni L; Zennaro M; Fumagalli G
    G Clin Med; 1979 Jun; 60(6):475-89. PubMed ID: 381086
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction.
    Boothman-Burrell D; Delany SG; Flannery EM; Hancox RJ; Taylor DR
    N Z Med J; 1997 Oct; 110(1053):370-3. PubMed ID: 9364183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in some ventilation and respiration parameters in patients with chronic obstructive lung disease in prospective longitudinal study].
    Mayer M; Dúbrava I; Petrîk V; Mayerová S; Bielik L
    Z Erkr Atmungsorgane; 1982; 159(3):252-8. PubMed ID: 7184218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in immunoglobulins in the sputum and serum after the use of secretolytics in patients with chronic obstructive pulmonary disease].
    Prazić B; Acketa M; Obradović-Andelić S; Volf-Pavlović E
    Plucne Bolesti; 1985; 37(3-4):178-82. PubMed ID: 3836422
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhalation therapy with selective beta 2-sympathomimetic drugs. Effect of pirbuterol administered via the Autohaler and salbutamol administered via the Diskhaler in obstructive respiratory tract disease].
    Hoffarth HP; Freyberger H; Völkl KP; Ulmer WT
    Fortschr Med; 1990 Mar; 108(8):162-4. PubMed ID: 2186991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
    Grönke L; Schlenker J; Holz O; Out TA; Magnussen H; Jörres RA
    Respir Med; 2005 Oct; 99(10):1241-8. PubMed ID: 16140224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
    Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
    Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
    Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of inhaled anticholinergic drug on dyspnea and on the physiologic function of respiratory system in patients with chronic obstructive pulmonary disease].
    Teramoto S; Suzuki M; Matsuse T; Ohga E; Katayama H; Fukuchi Y; Ouchi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1209-14. PubMed ID: 9493448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.